Literature DB >> 22527879

Monitoring of Epstein-Barr virus load in patients after allogeneic hematopoietic stem cell transplantation.

P Volfova, M Lengerova, J Winterova, Z Racil, D Dvorakova, J Mayer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22527879     DOI： 10.1007/s15010-012-0262-5

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  11 in total

Review 1.  How I treat EBV lymphoproliferation.

Authors:  Helen E Heslop
Journal:  Blood       Date:  2009-09-01       Impact factor: 22.113

Review 2.  Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.

Authors:  Margaret L Gulley; Weihua Tang
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

3.  Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation.

Authors:  J W van Esser; H G Niesters; S F Thijsen; E Meijer; A D Osterhaus; K C Wolthers; C A Boucher; J W Gratama; L M Budel; B van der Holt; A M van Loon; B Löwenberg; L F Verdonck; J J Cornelissen
Journal:  Br J Haematol       Date:  2001-06       Impact factor: 6.998

4.  Comparison of various blood compartments and reporting units for the detection and quantification of Epstein-Barr virus in peripheral blood.

Authors:  H Hakim; C Gibson; J Pan; K Srivastava; Z Gu; M J Bankowski; R T Hayden
Journal:  J Clin Microbiol       Date:  2007-05-09       Impact factor: 5.948

5.  Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay.

Authors:  H Kimura; M Morita; Y Yabuta; K Kuzushima; K Kato; S Kojima; T Matsuyama; T Morishima
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

6.  Prompt versus preemptive intervention for EBV lymphoproliferative disease.

Authors:  Hans-Joachim Wagner; Yee Chung Cheng; M Helen Huls; Adrian P Gee; Ingrid Kuehnle; Robert A Krance; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop
Journal:  Blood       Date:  2004-01-29       Impact factor: 22.113

7.  EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT.

Authors:  S Ocheni; N Kroeger; T Zabelina; I Sobottka; F Ayuk; C Wolschke; A Muth; H Lellek; L Petersen; R Erttmann; H Kabisch; A R Zander; U Bacher
Journal:  Bone Marrow Transplant       Date:  2008-06-02       Impact factor: 5.483

Review 8.  Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development.

Authors:  D M Weinstock; G G Ambrossi; C Brennan; T E Kiehn; A Jakubowski
Journal:  Bone Marrow Transplant       Date:  2006-03       Impact factor: 5.483

Review 9.  Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.

Authors:  J Styczynski; H Einsele; L Gil; P Ljungman
Journal:  Transpl Infect Dis       Date:  2009-06-23       Impact factor: 2.228

Review 10.  Molecular monitoring of viral infections after hematopoietic stem cell transplantation.

Authors:  Per Ljungman
Journal:  Int J Hematol       Date:  2010-04-23       Impact factor: 2.319
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.